Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2022 Jul 19;28(50):e202201359. doi: 10.1002/chem.202201359

In Situ Grignard Metalation Method for the Synthesis of Hauser Bases

Simon Sengupta 1,+, Philipp Schüler 1,+, Helmar Görls 1, Phil Liebing 1, Sven Krieck 1, Matthias Westerhausen 1,
PMCID: PMC9546396  PMID: 35686618

Abstract

The in situ Grignard Metalation Method (iGMM) is a straightforward one‐pot procedure to quickly produce multigram amounts of Hauser bases R2N‐MgBr which are valuable and vastly used metalation reagents and novel electrolytes for magnesium batteries. During addition of bromoethane to a suspension of Mg metal and secondary amine at room temperature in an ethereal solvent, a smooth reaction yields R2N‐MgBr under evolution of ethane within a few hours. A Schlenk equilibrium is operative, interconverting the Hauser bases into their solvated homoleptic congeners Mg(NR2)2 and MgBr2 depending on the solvent. Scope and preconditions are studied, and side reactions limiting the yield have been investigated. DOSY NMR experiments and X‐ray crystal structures of characteristic examples clarify aggregation in solution and the solid state.

Keywords: amides, Grignard reaction, Hauser bases, magnesium, magnesocenes


Magnesium is an alkaline‐earth metal of low reactivity. Therefore, direct metalation of primary and secondary amines yielding Hauser bases is impossible. The addition of bromoethane to a suspension of Mg metal and amine in an ethereal solvent allows the smooth syntheses of large amounts of amidomagnesium bromides without intermediate work‐up procedures.

graphic file with name CHEM-28-0-g001.jpg

Introduction

The desperate need of highly reactive yet site‐selective and stereospecific metalation reagents led to the development of diverse organometallics [1] such as homometallic Grignard reagents (RMgX) [2] and Hauser bases (R2N−MgX) [3] as well as heterobimetallic Lochmann‐Schlosser bases (RLi/KOR’) [4] and inverse crowns (Mulvey reagents, for example MI/MII(NR2)3) (MI=alkali metal, MII=Mg, Zn). [5] The LochmannSchlosser bases and Mulvey reagents are bimetallic organometallics and represent an advancement of unimetallic mixtures of two compounds such as LiR/LiOR’ or NaNH2/NaR with different anionic bases. [6] Conversion of classical Grignard reagents and Hauser bases into heterobimetallic mixtures via addition of lithium halide alters their chemical behavior and often enhances reactivity and selectivity. Therefore, these reagents are addressed as turbo‐Grignard reagents (turbo‐Knochel reagents, RMgX/LiX) [7] and turbo‐Hauser reagents (R2N‐MgX/LiX). [8] Most commonly, moderately bulky diisopropylamido and 2,2,6,6‐tetramethylpiperidino magnesium halides, (iPr2N)MgX and (tmp)MgX, as well as their lithium halide adducts were applied in selective metalation reactions. However, elucidation of reaction mechanisms is quite challenging because these solutions contain diverse species, which are interconnected by interfering aggregation‐deaggregation equilibria and Schlenk‐type ligand scrambling. Alternatively, heavy Grignard reagents such as calcium‐based organometallics also exhibit significantly enhanced metalation power, occasionally leading to ether degradation side reactions. [9] Despite the fact that Hauser and coworkers [10] firstly explored synthesis and chemical behavior of amidomagnesium halides more than 70 years ago, these reagents gained tremendous interest in recent years mainly as regio‐ and occasionally stereoselective reagents. These Hauser bases have commonly been prepared via metalation of secondary amines with Grignard reagents. Despite extensive use of these amidomagnesium halides in inorganic, organic and organometallic chemistry, it has been recognized that the solution structures of the Hauser and turbo‐Hauser bases depend on solvent and temperature as well as on the substitution pattern of the amide. Stalke and coworkers [11] employed DOSY NMR techniques to elucidate the multifaceted solution structures to identify the reactive species. Recently, we established a convenient and straightforward method to synthesize bis(trimethylsilyl)amido‐magnesium halides (hmds)MgBr in a multigram scale. [12] Due to the fact that amines cannot be deprotonated by magnesium metal, Mg and bis(trimethylsilyl)amine H(hmds) are suspended in an ethereal solvent and bromoethane is added. In this in situ Grignard metalation method (iGMM), intermediately formed EtMgBr smoothly metalates the amine yielding (hmds)MgBr as depicted in Scheme 1 (R=SiMe3). This method also allowed the synthesis of carbazolyl‐based Hauser and turbo‐Hauser bases, (carb)MgBr and (carb)MgBr⋅LiX (X=Cl, Br), and the exploitation of these heteroleptic complexes as electrolytes in magnesium batteries.[ 13 , 14 ]

Scheme 1.

Scheme 1

General synthesis of amidomagnesium halides (Hauser bases) via the in situ Grignard metalation method (iGMM).

The initial promising investigations convinced us to study scope and limitations of this preparative strategy. In this study suitability of different solvents and applicability of diverse secondary amines for the iGMM were elucidated. In addition, characteristic derivatives of Hauser bases were structurally authenticated to visualize aggregation and coordination in the crystalline state.

Results and Discussion

Scope of the iGMM

In a general procedure, magnesium turnings and H(hmds) were suspended in THF and addition of bromoethane yielded nearly quantitatively heteroleptic (hmds)MgBr within three hours as depicted in Scheme 2. [12] This benchmark reaction was used to monitor the suitability of different solvents for the iGMM because the bis(trimethylsilyl)amides of magnesium were highly soluble in common organic solvents. In a standardized protocol, 1.0 equiv. of Mg granules and 1.0 equiv. of H(hmds) were combined in the solvent at 20 °C. Then 1.1 equiv. of bromoethane were added and after three hours an aliquot of the clear reaction mixture was hydrolyzed with 0.1 N sulfuric acid. Titration against phenolphthalein allowed calculation of the conversion rate (Table 1).

Scheme 2.

Scheme 2

Benchmark reaction for clarification of the suitability of organic Lewis basic solvents L for the synthesis of Hauser bases via the iGMM. Reaction conditions are given at the first reaction arrow. In some cases, Schlenk‐type equilibria were observed, interconverting heteroleptic into homoleptic compounds (see text and Table 1).

Table 1.

Influence of the Lewis basic solvent L on the conversion rate and on the Schlenk‐type equilibrium (see Scheme 2).

Entry

Solvent L[a]

Conv./%[b]

Ratio/%[c]

δ(29Si)/ppm[d]

1

THF

92

83

−8.41/−9.46

2

2‐MeTHF

92

>95

−8.18/–

3

Et2O

94

>95

−7.19/–

4

THP

88

−7.89/−8.67

5

MTBE

93

>95

−7.42/–

6

Diox

71

7

Methylal

23

87

−7.98/−8.72

8

DME

21

15

−9.14/−9.54

9

Triglyme

57

<5

–/−9.64

[a] Solvents: tetrahydropyran THP, methyl‐tert‐butyl ether MTBE, 1,3‐dioxolane Diox, di(methoxy)methane Methylal, 1,2‐dimethoxyethane DME, 1,2‐bis(2‐methoxyethoxy)ethane Triglyme. [b] Conversion of H(hmds) under the given reaction conditions. [c] Percentage of the Hauser base in the Schlenk‐type equilibrium (determined by 29Si NMR; ratio=[Hauser base]/sum of integrals). [d] Chemical 29Si NMR shifts for (hmds)MgBr/Mg(hmds)2.

In monodentate ethers (Table 1, entries 1 to 5) a quantitative conversion of H(hmds) to the corresponding ether adducts of (hmds)MgBr was observed by 29Si NMR spectroscopy. The Schlenk‐type equilibrium was far on the side of the heteroleptic complexes, the real Hauser bases. 1,3‐Dioxolane (entry 6) is unable to act as a bidentate Lewis base at one Mg atom, but this ether could occupy bridging positions between two magnesium centers. This property obviously reduced the conversion rate. Di(methoxy)methane (methylal, entry 7) and 1,2‐dimethoxyethane (dme, entry 8) have rather small bite angles and in both cases, low conversion rates were observed. In contrast, tridentate triglyme (entry 9) led to a moderate conversion rate. In addition to the strong influence of the solvent on the conversion rate, the nature of the solvent (base strength and denticity) also affected the Schlenk‐type equilibrium. It is noteworthy that the formation of the homoleptic species is favored in the oligodentate Lewis bases DME and triglyme whereas in methylal with a very small bite the formation of the heteroleptic Hauser‐type complex is preferred.

The influence of the halide on the iGMM and on the Schlenk‐type equilibrium was studied, too. For this purpose, nBuCl, EtBr and EtI were used to initiate the magnesiation of H(hmds) in THF at room temperature, applying an exact 1.0 : 1.0 molar ratio of Mg and RX (Scheme 3). Several factors are influenced by the hardness of the halide: (i) ionicity of the Mg−X bond (and hence the salt character), (ii) preferred coordination and (iii) strength of the C−X bond. In general, the Grignard‐type reaction, i.e. the insertion of Mg into the C−X bond (umpolung of the carbon atom), proceeded more smoothly with increasing radius of the halogen atom. The hardness of the halide determined the preferred coordination behavior in dinuclear Hauser bases; small chloride ions occupied bridging positions as observed for for example (thf)Mg(tmp)Cl [15] and (Et2O)Mg(hmds)Cl [16] whereas the soft iodide ions favored terminal binding modes and then the amido ligands were in bridging positions (depending on the bulkiness of the amido substituents).

Scheme 3.

Scheme 3

Influence of the alkyl halide on the iGMM in THF at 20 °C (see text and Table 2).

In Table 2, the result of this investigation is summarized. The use of chlorobutane required prolonged reaction times for satisfactory conversion rates (entry 1). The best choice was bromoethane (entry 2) which was also applied in the benchmark reaction of Scheme 2. Surprisingly, iodoethane (entry 3) did not lead to shorter reaction periods but to significantly lower conversion rates even after long reaction times.

Table 2.

Influence of the alkyl halide on the conversion rate and on the Schlenk‐type equilibrium (see Scheme 3).

Entry

R‐X

Conv./% (3 h)[a]

Conv./% (18 h)[b]

Ratio/ %[c]

δ(29Si)/ ppm[d]

1

nBu−Cl

2

75

77

−8.80/−9.64

2

Et−Br

78

82

83

−8.44/−9.50

3

Et−I

21

32

<5

–/−9.53

4

Ph−Br

95

75

−8.44/−9.51

[a] Conversion of H(hmds) under the given reaction conditions after 3 h. [b] Conversion of H(hmds) under the given reaction conditions after 18 h. [c] Percentage of the Hauser base in the Schlenk‐type equilibrium (determined by 29Si NMR; ratio=[Hauser base]/sum of integrals). [d] 29Si NMR chemical shifts for (hmds)MgX/Mg(hmds)2.

Substrate screening was performed applying the optimized conditions and using a suspension of Mg granules, secondary amine and bromoethane in THF at 20 °C as depicted in Scheme 4. After three hours the reaction mixture was quenched with sulfuric acid (aryl substituted amines) or benzoic acid (alkylamines) and the amount of formed amide was determined by titration. We focused on the conversion, i.e. consumption of the secondary amine during the iGMM. Representative examples were chosen, including acyclic and cyclic amines as well as alkyl and aryl substituted ones.

Scheme 4.

Scheme 4

Substrate screening for the iGMM in THF at 20 °C (see text and Table 3).

The conversion of the secondary amines in dependency of the substituents according to Scheme 4 is summarized in Table 3. As described above, the synthesis of (hmds)MgBr/Mg(hmds)2 via the benchmark reaction (entry 1) is quantitative under these reaction conditions. In addition, substituted anilines (entries 2–4) also represent beneficial substrates for this protocol. The yields are lower for diisopropylamine (entry 5) due to a decelerated conversion rate. Cyclic amines (piperidines, entries 6–8) show an unexpected trend because increasing methylation in 2,6‐positions (and hence increasing steric hindrance) enhances the yields under the applied reaction conditions. The rate of conversion to the amide depended on the temperature for 2,6‐dimethyl‐ and 2,2,6,6‐tetramethylpiperidide formation (entries 7 and 8) and at 0 °C a complete conversion was observed whereas at room temperature side reactions interfered with the amide formation (see below). For unsubstituted piperidine (entry 6) another side reaction took place and minor amounts of piperidylethane formed.

Table 3.

Screening of the amine substrates with respect to conversion rate in the iGMM in THF at 20 °C and within three hours (see Scheme 4).

Entry

Substrate[a]

Conv./%[b]

Entry

Substrate[a]

Conv./%[b]

1

H(hmds)

>99

5

HN(iPr)2

65

2

HNPh2

95

6

H(pip)

0

3

HN(Me)Ph

81

7

H(dmp)

68, >95[c]

4

HN(C6F5)2

96

8

H(tmp)

74, >99[c]

[a] Substrates: hexamethyldisilazane H(hmds), piperidine H(pip), dimethylpiperidine H(dmp), tetramethylpiperidine H(tmp). [b] Conversion of the H‐acidic substrate under the given reaction conditions (see text and Scheme 4). [c] Reaction temperature: 0 °C.

To shed light on the factors that influence the outcome of the iGMM, we altered the reaction conditions for the magnesiation of H(dmp) and H(tmp) according to the iGMM protocol (Scheme 4, Table 4). Lower reaction temperatures (entries 3 and 5) were advantageous whereas the concentrations played an insignificant role (entries 3 and 7). Larger excess of magnesium (entries 4 and 7) was advantageous to compensate loss due to Wurtz‐type coupling reactions. The influence of the ethereal solvent THF or diethyl ether (entries 3, 7 and 9) was negligible. Performance of the iGMM in the presence of lithium chloride with the objective to form turbo‐Hauser base reagents did not enhance the yield (entry 8).

Table 4.

Influence of reaction conditions on the conversion of 2,6‐dimethyl (dmp) and 2,2,6,6‐tetramethylpiperidine to the corresponding piperidide anions (see Scheme 4).

Entry

Amine

Solvent

Conc./ mol/L

Temp./ °C

Eq. Mg

Conv./ %[a]

1

H(dmp)

THF

0.5 M

r.t.

1.0

68

2

H(dmp)

THF

0.25 M

0

2.0

100

3

H(tmp)

THF

0.5 M

0

1.3

92

4

H(tmp)

THF

0.25 M

0

1.9

100

5

H(tmp)

THF

0.5 M

r.t.

1.3

74

6

H(tmp)

THF

0.25 M

r.t.

1.3

80

7

H(tmp)

THF

0.25 M

0

1.3

92

8

H(tmp)+1 equiv. LiCl

THF

0.5 M

0

1.3

86

9

H(tmp)

Et2O

0.4 M

0

1.3

87

[a] Amide formation under the given reaction conditions after 3 h.

In Table 5 the iGMM (Scheme 4) was monitored for cyclic unsaturated amines. The cyclic amines carbazole [14] (entry 1) and indole (entry 2) as well as phenothiazine (entry 7) reacted quantitatively with Mg in THF at 20 °C within three hours after addition of bromoethane. The unsubstituted small five‐membered heterocycles pyrrole (entry 3), imidazole (entry 6) and pyrazole (entry 8) showed moderate conversion under the applied conditions whereas enhanced solubility and yields were seen with methyl‐substitution (entries 4, 5 and 10). In contrast to this finding, aryl substituents lowered the conversion rate (entries 9, 11 and 12) due to favored Wurtz‐type coupling reactions and hence formation of butane and magnesium bromide.

Table 5.

Screening of 0.5 M THF solutions of cyclic and unsaturated amine substrates with respect to conversion rate in the iGMM at 20 °C until the reaction ceased (see Scheme 4).

Entry

Substrate

Conv./%[a]

1

Carbazole H(carb) [13]

96[b]

2

Indole H(ind)

96

3

Pyrrole

58

4

2,4‐Dimethylpyrrole

90

5

2,5‐Dimethylpyrrole

82

6

Imidazole

22

7

Phenothiazine

88

8

Pyrazole

48

9

p‐Tolylpyrazole

17

10

3,5‐Dimethylpyrazole

82[b]

11

3,5‐Diphenylpyrazole

4

12

5‐Phenyl‐1H‐tetrazole

0

13

N,N’‐Di(2,6‐diisopropylphenyl)formamidine

44

[a] Conversion of the H‐acidic substrate under the given reaction conditions (see text and Scheme 4). [b] 1.5 equivalents of EtBr were added.

Magnesium amidinates represent an established compound class with manifold applications such as for example stabilization of very reactive magnesium complexes or reagents. [18] For this purpose, bulky N‐bound aryl groups proved to be beneficial shielding substituents. Contrary to aryl substituted unsaturated heterocycles, acyclic N,N’‐diarylamidines represent suitable substrates for the iGMM even with bulky 2,6‐diisopropylphenyl (Dipp) groups (entry 13). Under standardized reaction conditions, a moderate yield of 44 % for amidinate formation according to Scheme 5 was observed. This procedure led to formation of the homoleptic product as depicted in Scheme 5 and the NMR parameters were identical to published ones. [17] Again, this conversion competed with the Wurtz‐type coupling reaction yielding butane and magnesium bromide and therefore, larger amounts of Mg and EtBr would be required for quantitative conversion of the amidine. Heteroleptic dinuclear N,N’‐bis(2,6‐diisopropylphenyl)formamidinato magnesium chloride with bridging chloride ligands was prepared earlier by transmetalation of an intermediately formed formamidinato bismuth dichloride compound with magnesium metal. [19]

Scheme 5.

Scheme 5

Formation of magnesium bis[N,N’‐bis(2,6‐diisopropylphenyl)formamidinate] in tetrahydrofuran at room temperature via the iGMM (see text).

The reaction of 3,5‐dimethylpyrazole was much more complex than found for the other substrates. In the 1H NMR spectrum, several species were detected. DOSY and ECC‐DOSY NMR experiments verified the presence of four compounds as depicted in Scheme 6. The dinuclear 3,5‐dimethylpyrazolato magnesium bromides formed transannular cisoid and transoid isomers as shown at the top of Scheme 6. Magnesium bromide (MgBr2), which formed during the Wurtz‐type coupling reaction, could form an adduct with these dimers leading to unimetallic complexes as depicted in the bottom row of this scheme.

Scheme 6.

Scheme 6

Formation of [(Et2O)Mg(PzMe2)(Br)]2 in diethyl ether at room temperature via the iGMM and interconversion of transannular trans‐ and cis‐isomer as well as of their magnesium bromide adducts (see text, additionally Figure S 40–42).

Two reasons could account for lower conversion rates. In all cases, very similar formation rates of EtMgBr could be assumed and a decelerated conversion would be caused by hindered magnesiation of the secondary amines. Incomplete conversion could be explained by sparingly soluble magnesium amides covering the magnesium particles.

Primary p‐methylaniline (p‐tolylamine, p‐toluidine) reacted in a similar way as the secondary amines. Thus p‐toluidine and magnesium granules were suspended in diethyl ether and bromoethane was added within 30 minutes at room temperature. After addition of the first equivalent of EtBr, a colorless solid precipitated which redissolved during the addition of a second equivalent. After refluxing of the reaction mixture for a few hours and addition of 1,4‐dioxane (dx) to precipitate magnesium bromide, the colorless magnesium imide [{(Et2O)Mg}6(N‐pTol)43‐Br)4] was isolated with a yield of 59 % according to Scheme 7. This structure is thermodynamically favored and it was impossible to precipitate further magnesium halide by the dioxane strategy as described earlier for Grignard reagents. [20] The central Mg6N4 cage shows an adamantane‐like structure, verified by an X‐ray structure determination (see below), as had been observed earlier for the phenyl congener [{(Et2O)Mg}6(N−Ph)43‐Br)4] which had been prepared via the classical metalation of aniline with ethylmagnesium bromide in diethyl ether. [21] In ethereal solutions, this cage compound retained its molecular structure as was verified by DOSY NMR spectroscopy.

Scheme 7.

Scheme 7

Synthesis of the magnesium imide [{(Et2O)Mg}6(N‐pTol)43‐Br)4] in diethyl ether at room temperature. The green lines clarify the Mg6N4 hetero adamantane cage.

Bulkier 2,6‐diisopropylaniline (2,6‐diisopropylphenylamine) can be magnesiated once in a very similar procedure in diethyl ether. However, a second deprotonation with another equivalent of ethylmagnesium reagent is impossible and excess of EtMgBr/MgEt2 can be observed besides heteroleptic [(Et2O)xMg(NH‐Dipp)2‐mBrm] (m=0, 1; see Figures S23–S26).

Magnesocenes, i.e. substituted bis(cyclopentadienyl)magnesium complexes, are a well‐established and intensely studied substance class of broad interest. [22] Most commonly, cyclopentadienes have been metalated with Mg‐based organometallics; an alternative is the addition of such reagents onto fulvenes. [23] The magnesium ions are effectively shielded by two parallel cyclopentadienide ligands leading to thermodynamically and kinetically stabilized compounds. In heteroleptic (substituted) cyclopentadienylmagnesium halides the Mg atoms are accessible for substrate molecules allowing transformations at the alkaline‐earth metal atom. Heteroleptic Cp'MgX (X=Cl, Br) are far less investigated and depending on the donor strength and the bulkiness of the coligands and of the Cp’ anions, mononuclear or dinuclear molecules with bridging halide ions have been isolated; examples are [{(Me3Si)3C5H2}Mg(tmeda)Br], [24] [Cp'Mg(thf)(μ‐Br)]2 (Cp’=C5Me4H, Cp*), [25] [CpMg(Py)(μ‐Br)]2, [26] and [(Cp*)Mg(Dmf)(μ‐Br)]2. [27] In addition, the dinuclear chlorido complexes [CpMg(OEt2)(μ‐Cl)]2 and [(Cp*)Mg(OEt2)(μ‐Cl)]2 have been reported. [28]

Therefore, we extended our elucidation of the scope of the iGMM also on the CH‐acidic cyclopentadiene derivatives C5H6 (CpH), [29] triisopropylsilylcyclopentadiene [(iPr3Si)C5H5, TIPSCpH] [29] and bulkier 1,3‐bis(tert‐butyldimethylsilyl)cyclopentadiene [1,3‐(tBuMe2Si)2C5H4, TBDMS2CpH]. Magnesium turnings and the (substituted) cyclopentadienes were suspended in diethyl ether and then bromoethane was added at room temperature. As observed for unstrained CpH and TIPSCpH, [29] sterically more shielded 1,3‐bis(tert‐butyldimethylsilyl)cyclopentadiene TBDMS2CpH reacted very similar, yielding [(Et2O)Mg(TBDMS2Cp)(μ‐Br)]2 as depicted in Scheme 8.

Scheme 8.

Scheme 8

Formation of [(Et2O)Mg(TBDMS2Cp)(μ‐Br)]2 in diethyl ether at room temperature via the iGMM (see text).

Side reactions

There exist two possible side reactions which could interfere with the amide formation. The first step is the (rather slow) classical Grignard reaction leading to EtMgBr. This highly reactive reagent could either react with still present bromoethane to butane and magnesium bromide (Wurtz‐type coupling) or with already formed magnesium amide to an ethyl amine (salt metathesis reaction) as depicted in Scheme 9. In the first case, addition of another equivalent of bromoethane and magnesium would enhance the yield, in the latter case, additional EtBr would have no impact on the final yield. A lower temperature reduces side products, and an enhanced yield was obtained (Table 3, entry 7).

Scheme 9.

Scheme 9

Formation of side products via Wurtz‐type coupling (a) and salt metathesis reactions (b) in THF (see text).

For some kinetic studies the reaction solutions were kept in a sealed NMR tube to also monitor the formation of ethane. During this procedure, traces of another side product were observed during the iGMM, namely ethene. This small molecule H2C=CH2 assumedly formed via β‐hydride elimination from the Grignard reagent ethylmagnesium bromide. Therefore, we repeated the Grignard reaction of magnesium with bromoethane in an ethereal solution in the absence of additional H‐acidic substrates (such as amines and cyclopentadienes) in a sealed NMR tube. Again, small amounts of ethene of up to a few percent formed verifying that β‐hydride elimination is a common accompanying process during the formation of Grignard reagents; however, this molecule remains undiscovered in common procedures because it escapes during working in open Schlenk flasks and systems. In Figure 1, the formation of ethene is monitored for the iGMM of (tmp)MgBr (spectrum a) and during the preparation of the EtMgBr Grignard reagent in the absence of an amine (spectrum b). The remaining hydrido magnesium species were insoluble and hence we were unable to detect MgH functionalities by NMR spectroscopy because bulky ligands are required to produce molecular and soluble hydrido magnesium compounds. [30] In addition, it could not be excluded that the hydrido magnesium compounds acted as metalation reagents towards the amine. Obviously, this β‐hydride elimination was an imminent process during formation of EtMgBr and could not be circumvented but a slight excess of Mg and EtBr rendered this degradation reaction harmless. We could exclude that ethene formed due to ether degradation reactions. If the iGMM was performed in [D8]THF, the same amount of ethene was detected and no deuterated ethene was observed. In addition, repetition of this reaction with bromocyclohexane gave similar amounts of cyclohexene.

Figure 1.

Figure 1

1H NMR (400 MHz, [D8]‐THF (#), 297 K) spectroscopic detection of ethene during the iGMM of (tmp)MgBr in THF (a) and during the preparation of the EtMgBr Grignard reagent in THF in the absence of an amine (b) in sealed NMR tubes (chemical shifts: ethane 0.83 ppm, ethene 5.34 ppm, EtMgBr 1.16 ppm and −0.75 ppm; * residual EtBr).

Ethereal ethylmagnesium bromide solutions are stable at room temperature. The β‐hydride elimination process requires the presence of metal particles suggesting degradation of the ethyl fragment on the metal surface as depicted in Figure 2. In agreement with common mechanistic concepts, [31] the first reaction step on the metal surface is a single electron transfer from Mg onto bromoethane yielding the bromoethane radical anion. Then the bromide ion is liberated whereas the ethyl radical is trapped on the metal surface. Now the second electron transfer leads to formation of the Grignard reagent EtMgBr as the major pathway. However, a minor process may involve an electron transfer onto the β‐hydrogen atom yielding ethene and a hydride ion as depicted in Figure 2.

Figure 2.

Figure 2

Proposed mechanism for the β‐hydride elimination process yielding ethene.

A quantitative comparison of ethene evolution during a classical Grignard reaction of Mg with EtBr in THF and after addition of EtBr to a suspension of Mg granules and secondary amine in THF is depicted in Figure 3. The presence of amine slightly accelerated the ethene liberation but the amount of formed ethene is comparable for both procedures. After consumption of bromoethane the formation of ethene ceased verifying the stability of the Grignard reagent itself.

Figure 3.

Figure 3

Ethene evolution during the Grignard reaction of magnesium with bromoethane (blue) and during the iGMM after addition of bromoethane to a suspension of Mg turnings and secondary amine in THF (red).

NMR Spectroscopic Studies

To monitor the iGMM, bromoethane was added to a suspension of 3,6‐dimethylcarbazole [H(carb‐3,6‐Me2)] and magnesium in [D8]THF at room temperature as depicted in Scheme 10. The methyl groups of this heterocyclic derivative allowed to monitor the proceeding reaction.

Scheme 10.

Scheme 10

Magnesiation of 3,6‐dimethylcarbazole in THF at room temperature after addition of bromoethane according to the iGMM yielding [(thf)3Mg(carb‐3,6‐Me2)Br] (see text and for the NMR spectra Figure 1).

The methyl groups could be observed in the 1H NMR spectrum at approx. 2.5 ppm (Figure 4). Within several hours, the resonances of the substrate H(carb‐3,6‐Me2) vanished and the intensity of the signals of the magnesium complex [(thf)3Mg(carb‐3,6‐Me2)Br] increased. In this smooth and straightforward procedure, no side products were recognized. Up to a few hours the substrate bromoethane and the product ethane could be observed at the same time. This slow conversion guaranteed a smooth progression of the metalation reaction. The intermediately formed ethylmagnesium bromide was not identified in this reaction mixture because formation of the Grignard reagent was slower than its consumption.

Figure 4.

Figure 4

1H NMR (400 MHz, [D8]‐THF, 297 K) spectroscopic monitoring of the iGMM, using 3,6‐dimethylcarbazole in THF. Spectrum a shows unreacted 3,6‐dimethylcarbazole (#), the bottom spectra show the proceeding reaction (b after 10 min, c after 2 h, d after 3 d; EtBr (+)) and formation of 3,6‐dimethylcarbazolylmagnesium bromide (*).

Contrary to this reaction, the conversion of toluidine to the magnesium complex [{(Et2O)Mg}6(N‐pTol)4Br4] (according to Scheme 6) clearly showed the intermediate formation of ethylmagnesium bromide as depicted in Figure 5. Even after four days, a small amount of EtMgBr Grignard reagent was still present. The reason for this behavior was the very slow magnesiation after the first deprotonation step because the second deprotonation reaction required the removal of a proton from an anionic p‐tolylamide. In agreement with this interpretation, several tolyl groups could be detected in the methyl region of the 1H NMR spectrum around 2.2 ppm.

Figure 5.

Figure 5

1H NMR spectroscopic monitoring of the iGMM, using toluidine in THF. Spectrum a shows the solution of crystalline [{(Et2O)Mg}6(N‐pTol)4Br4] in [D8]THF, at 0 ppm the resonance of Si(SiMe3)4 is shown. Spectrum c was recorded after one hour, spectrum b after four days.

Molecular Structures

Slow cooling of a THF solution of Ph2N‐MgBr gave crystals of a tetragonal polymorph of the homoleptic magnesium bis(amide) [(thf)2Mg(NPh2)2]; a monoclinic polymorph has been reported earlier. [32] Molecular structure and atom labelling scheme are depicted in Figure 6. The magnesium atom is in a distorted tetrahedral environment of two thf and two amido ligands. The Mg−N and Mg−O distances are equal within the estimated standard deviations. In each diphenylamido ligand the lone pair at the nitrogen atom is aligned with the π‐system of only one phenyl group leading to a significant shortening of these N1−C7 and N2−C13 bonds by approx. 4 pm compared to the other N1−C1 and N2−C19 values. Tetra‐coordination of bridging diphenylamido ligands (as in [CpMg{μ‐NPh2]2) [33] prevent such a charge backdonation into the phenyl group and hence, longer N−C bonds are observed.

Figure 6.

Figure 6

The molecular structure and atom labelling scheme of [(thf)2Mg(NPh2)2]. The ellipsoids represent a probability of 30 %, H atoms are omitted for the sake of clarity. Selected bond lengths (pm): Mg1−N1 200.7(3), Mg1−N2 200.6(3), Mg1−O1 200.8(3), Mg1−O2 201.0(3), N1−C1 141.2(4), N1−C7 137.7(4), N2−C13 137.4(4), N2−C19 142.0(4); angles (deg.): N1−Mg1‐N2 125.12(13), N1−Mg1−O1 106.68(12), N1−Mg1−O2 109.57(12), N2−Mg1−O1 109.64(13), N2−Mg1−O2 105.89(12), O1−Mg1−O2 96.12(11).

Molecular structure and atom labelling scheme of heteroleptic [(thf)3Mg{N(C6F5)2}Br] is depicted in Figure 7. Due to a small Mg1⋅⋅⋅F1 contact the magnesium atom is in a distorted octahedral coordination sphere, leading to an elongation of the Mg1−N1 bond by approx. 12 pm. The anionic amido and bromide ligands are cis‐arranged and Br1 is in a trans‐position to the Mg1⋅⋅⋅F1 contact. The back bonding of one pentafluorophenyl substituent enforces a planar arrangement of this Mg−N−C6F5 moiety and a back donation of negative charge from the pz(N) lone pair into the aryl group leading to a shortened N1−C1 bond by 3 pm. The strong Mg1⋅⋅⋅F1 interaction elongates the C2−F1 bond by approx. 2 pm. Such Mg⋅⋅⋅F bonds have been observed earlier for [(hmds)Mg{N(C6F5)2}]2 and the homoleptic derivatives [(thf)2Mg{N(C6F5)2}2], [(Et2O)2Mg{N(C6F5)2}2] and [Mg{N(C6F5)2}2]2. [34]

Figure 7.

Figure 7

The molecular structure and atom labelling scheme of [(thf)3Mg{N(C6F5)2}Br]. The ellipsoids represent a probability of 30 %, H atoms are neglected for clarity reasons. Selected bond lengths (pm): Mg1−N1 212.89(19), Mg1−Br1 252.13(7), Mg1−O1 210.58(17), Mg1−O2 210.55(17), Mg1−O3 205.77(17), Mg1−F1 228.61(14), C2−F1 136.8(2), N1−C1 136.7(3), N1−C7 139.7(3); angles (deg.): N1−Mg1−O1 91.96(7), N1−Mg1−O2 155.23(7), N1−Mg1−O3 94.38(7), N1−Mg1−Br1 103.65(6), N1−Mg1−F1 73.91(6), O1−Mg1−O2 83.74(7), O1−Mg1−O3 160.20(8), O1−Mg1−Br1 95.69(5), O1−Mg1−F1 78.66(6), O2−Mg1−O3 82.66(7), O2−Mg1−Br1 101.05(5), O2−Mg1−F1 81.34(6), O3−Mg1−Br1 100.99(5), O3−Mg1−F1 85.11(6), Br1−Mg1−F1 173.66(5).

Molecular structure and atom labelling scheme of [(thf)3Mg2(Pz)2Br2] are depicted in Figure 8. A very similar structure has been found for the 3,5‐diphenylpyrazolate derivative [(thf)3Mg2(PzPh2)2Br2] which contains two κ2 N,N’‐bridging pyrazolate‐type ligands, two terminal thf ligands and one bridging thf molecule. [35] Homoleptic magnesium bis(pyrazolates) prefer mononuclear structures as observed for [(tmeda)Mg(Pz tBu2)2] [36] and [(HPz tBu2)2Mg(Pz tBu2)2]. [37] Additional basic sites in the pyrazolyl side‐arms such as 3‐pyridyl‐5‐thienylpyrazolyl ligands can lead to stabilization of mononuclear heteroleptic pyrazolylmagnesium halides as observed for [(thf)3Mg(Pz3−Py−5−Th)Cl] (Pz3−Py−5−Th=3‐pyridyl‐5‐thienyl‐pyrazolate). [38] The penta‐coordinate magnesium atoms are in distorted trigonal bipyramidal environments with the thf bases in apical positions. The Mg1‐O2 bond to the bridging ether molecule is elongated by 26 pm compared to the terminal Mg1‐O1 value.

Figure 8.

Figure 8

The molecular structure and atom labelling scheme of [(thf)3Mg2(Pz)2Br2]. The ellipsoids represent a probability of 30 %, H atoms are omitted for the sake of clarity. Selected bond lengths (pm): Mg1−N1 206.1(3), Mg1−N2A 205.6(3), Mg1−Br1 247.7(11), Mg1−O1 207.9(3), Mg1−O2 233.9(2); angles (deg.): N1−Mg1−N2A 110.52(11), N1−Mg1−Br1 123.73(9), N1−Mg1−O1 94.77(12), N1−Mg1−O2 81.45(9), N2A−Mg1−Br1 123.34(9), N2A−Mg1−O1 95.00(11), N2A−Mg1−O2 81.71(9), Br1−Mg1−O1 95.62(8), Br1−Mg1−O2 90.69(7), O1−Mg1−O2 173.69(11).

Exchange of the thf bases by bulkier and less basic diethyl ether ligands reduces the coordination number of the metal atoms. Molecular structure and atom labelling scheme of dinuclear [(Et2O)Mg(Pz)Br]2 are depicted in Figure 9. The central structure is comparable to the corresponding thf adduct, but the bridging ether base is missing. Despite this change and hence related decrease of the coordination number, the Mg−N and Mg−Br bond lengths remain nearly unchanged. However, the Mg−O distance is significantly smaller than in the thf adduct where the thf bases occupy apical positions.

Figure 9.

Figure 9

The molecular structure and atom labelling scheme of [(Et2O)Mg(Pz)Br]2. The ellipsoids represent a probability of 30 %, H atoms are omitted for clarity reasons. Selected bond lengths (pm): Mg1−N1 205.74(14), Mg1−N2A 204.71(14), Mg1−Br1 247.18(6), Mg1−O1 203.60(13); angles (deg.): N1−Mg1−N2A 109.39(5), N1−Mg1−Br1 113.87(4), N1−Mg1−O1 106.67(6), N2A−Mg1−Br1 111.94(4), N2A−Mg1−O1 107.61(6), Br1−Mg1−O1 107.01(4).

Molecular structure and atom labelling scheme of the magnesium imide [{(Et2O)Mg}6(N‐pTol)43‐Br)4] are depicted in Figure 10 and show the highly symmetric molecule along a C2 axis containing Mg1 and Mg1 A as well as the diethyl ether oxygen atoms O2 and O2 A. As delineated in Scheme 5, the molecule consists of an adamantane‐like Mg6N4 cage with an octahedral arrangement of the alkaline‐earth metal atoms (Mg⋅⋅⋅Mg distances 314.50(16) and 326.13(15) pm). Every second plane of the Mg6 octahedron is μ3‐bridged with a nitrogen atom, the other half of the planes is capped with bromine atoms. This structure gives tetrahedral arrangements of both the bromine atoms and the nitrogen atoms. In this cage compound, the penta‐coordinate magnesium atoms are in distorted trigonal bipyramidal coordination spheres with the bromine atoms in apical positions (Br1−Mg1−Br1A 170.46(6)° and Br1−Mg2−Br1B 170.74(4)°).

Figure 10.

Figure 10

The molecular structure and atom labelling scheme of [{(Et2O)Mg}6(N‐pTol)43‐Br)4]. The ellipsoids represent a probability of 30 %, H atoms are omitted for the sake of clarity. Selected bond lengths (pm): Mg1−N1 202.9(3), Mg1−N1A 202.9(3), Mg1−Br1 296.80(3), Mg1−Br1A 296.81(3), Mg1−O2 201.1(3), Mg2−N1 203.6(3), Mg2−N1C 204.1(3), Mg2−Br1 288.25(13), Mg2−Br1B 289.91(13), Mg2−O1 204.7(2); angles (deg.): N1−Mg1−N1A 120.20(16), N1−Mg1−Br1 90.76(7), N1−Mg1−Br1A 84.49(7), N1−Mg1−O2 119.90(8), N1A−Mg1−Br1 84.49(7), N1A−Mg1−O2 119.90(8), Br1−Mg1−Br1A 170.46(6), Br1−Mg1−O2 94.77(3), Br1A−Mg1−O2 94.77(3), N1−Mg2−N1C 117.26(13), N1−Mg2−Br1 93.07(8), N1−Mg2−Br1B 86.21(8), N1−Mg2−O1 111.46(10), N1C−Mg2−Br1 86.21(8), Br1−Mg2−Br1B 170.74(4), Br1−Mg2−O1 92.89(7), Br1B−Mg2−O1 96.07(7).

This structure is unique to the best of our knowledge and shows characteristic features. Two tolyl groups are bent toward Mg1 leading to rather short Mg1⋅⋅⋅C1 contacts of 271.7(3) pm to the ipso‐carbon atoms. This interaction elongates the Mg1−Br1 and Mg1−Br1A bonds (296.80(3) and 296.81(3) pm) whereas the Mg2‐Br1 and Mg2−Br1B distances (288.25(13) and 289.91(13) pm) are slightly smaller. The phenyl derivative [{(Et2O)Mg}6(N−Ph)43‐Br)4] is much more distorted and the Mg−Br bond lengths vary in a very broad range between 276 and 348 pm. [21] Halide‐free arylimido magnesium derivatives of the type [(thf)Mg(NAr)]6 (Ar=Ph, [39] 1‐Naph [40] ) contain hexagonal Mg6N6 prisms with comparable Mg−N and Mg−O bond lengths (Table 6) which can be described as a (distorted) Mg6 octahedron, the nitrogen atoms cap six of the eight triangular faces. [41]

Table 6.

Comparison of selected bond lengths (pm) of the hexanuclear complexes [{(Et2O)Mg}6(N‐pTol)43‐Br)4] (I), [{(Et2O)Mg}6(N−Ph)43‐Br)4] (II), [(thf)Mg(NPh)]6 (III), and [(thf)Mg(NNaph)]6 (IV).

I

II

III

IV

Mg−Omin

201.1(3)

199.6

199.8

201.2(5)

Mg−Omax

204.7(2)

205.2

205.3

202.5(5)

Mg−Brmin

288.25(13)

276.1

Mg−Brmax

296.83)

333.7

Mg−Nmin

201.1(3)

201.9

200.0

202.2(5)

Mg−Nmax

204.1(3)

205.5

209.4

210.5(5)

Mg⋅⋅⋅Mgmin

314.50(16)

320.9

275.9

280.2

Ref.

[20]

[37]

[38]

The molecular structure and atom labelling scheme of [(Et2O)Mg(TBDMS2Cp)(μ‐Br)]2 are depicted in Figure 11. The structural influence of the tert‐butyldimethylsilyl (TBDMS) substituents on the central substructure are rather small compared to [(Et2O)Mg(Cp)(μ‐Br)]2 (Mg−Br 257.8(2) and 260.9(2), Mg−O 204.4(5) pm) and [(Et2O)Mg(TIPSCp)(μ‐Br)]2 (Mg−Br 258.03(7) and 261.94(8), Mg−O 206.92(16) pm). [29] In the nearly square Mg2Br2 ring the Mg−Br distances are very similar, supporting rather low steric pressure induced by the bulky TBDMS2Cp anions. Furthermore, the Mg−O bond lengths to the ligated diethyl ether molecules are comparable to those of [(Et2O)Mg(Cp)(μ‐Br)]2 and [(Et2O)Mg(TIPSCp)(μ‐Br)]2.

Figure 11.

Figure 11

The molecular structure and atom labelling scheme of [(Et2O)Mg(TBDMS2Cp)Br]. The ellipsoids represent a probability of 30 %, H atoms are omitted for the sake of clarity. Selected bond lengths (pm): Mg1A−O1A 206.4(3), Mg1A−Br1A 259.28(12), Mg1A−Br1C 261.76(13), Mg1A−C1A243.7(3), Mg1A−C2A 243.0(4), Mg1A−C3A 243.7(3), Mg1A−C4A 243.4(4), Mg1A−C5A 239.7(3), C1A−Si1A 185.4(4), Si1A−C6A 186.9(4), SiA−C7A 187.4(4), Si1A−C8A 190.6(4), C4A−Si2A 185.1(4), Si2A−C12A 186.6(4), Si2A−C13A 186.7(4), Si2A−C14A 191.3(4).

Validation of the iGMM

Magnesium is an abundant, environmentally benign and non‐toxic alkaline‐earth metal and, hence, a very attractive basis for organometallics with multifaceted applications. However, low reactivity of the metal prohibits direct metalation of many H‐acidic substrates such as amines, amidines and cyclopentadienes. Therefore, metal activation is often required to enhance the reactivity. Recent developments aim toward time‐economic and resource saving procedures.

Novel protocols for the preparation of highly reactive organomagnesium reagents were developed to circumvent multiple step processes, solvent exchange during synthesis as well as time‐consuming and complicated work‐up procedures. Therefore, a one‐pot protocol was reported for the synthesis of pyrazolates and benzamidinates via intermediate phenylmagnesium iodide and 3,5‐diphenylpyrazolylmagnesium iodide and magnesium bis[N,N’‐dimesitylbenzamidinate] were isolated with yields of 82 % and 39 %, respectively. [42] Mechanochemistry had been advanced to prepare air‐ and moisture‐sensitive alkaline‐earth metal compounds by ball milling. [43] Highly reactive organometallic potassium beryllates [44] and magnesates [45] were prepared with moderate yields as proof of concept for mechanochemical organometallic chemistry. Even though the preparation succeeded solvent‐free, the product had to be extracted with an anhydrous organic solvent. Another novel device‐related procedure allowed the formation of turbo‐Hauser bases R2NMgCl⋅LiCl by running a mixture of 2‐chloropropane and secondary amine in THF and toluene through a column, the front half filled with Mg metal and the back half packed with LiCl. [46] A different fascinating one‐pot procedure involved a fluorous phase as liquid membrane between RI and Mg metal, covered with an organic solvent, yielding a system with three liquid phases and magnesium particles floating on the fluorous phase. [47] This setting required three liquid phases of significantly different density. RI slowly diffused through the fluorous phase and was reduced by magnesium yielding RMgI which immediately reacted with the substrate (such as ketones) dissolved in the organic top phase. This procedure was limited to iodomethane and iodoethane for density reasons and this iodoalkane phase vanished during the procedure, finally leading to a two‐phase system. The iGMM outperforms the settings described above. The suspension of Mg granules and H‐acidic substrate like amines smoothly reacted upon addition of inexpensive bromoethane within very few hours yielding magnesium reagents like Hauser bases. Activation of Mg prior to use was unnecessary. These solutions could be used directly for further reactions because in most cases no interfering side products formed. Side reactions such as Wurtz‐type coupling reactions enhance the amount of inert magnesium bromide, and butane is volatile and very unreactive. In only very few cases, intermediately formed EtBr reacted with already formed Hauser base leading to the formation of negligible amounts of undesired R2N−Et. Sparingly soluble Hauser base reagents could not be prepared by this iGMM because precipitate covered the metal particles and the reaction rather quickly ceased.

Conclusions

The in situ Grignard Metalation method (iGMM), i.e. the metalation of H‐acidic substrates with Mg granules after addition of EtBr, is a powerful tool for the synthesis of heteroleptic organylmagnesium bromides within a few hours. This smooth reaction is a straightforward strategy for large scale syntheses of heteroleptic Grignard‐type compounds. The presence of acidic hydrogen atoms is a precondition for this method, but the pKa values alone are not too meaningful. Insoluble or sparingly soluble products precipitate and cover the magnesium particles which disrupts the smooth continuation of this metalation reaction. This finding limits the choice of solvent because heteroleptic organylmagnesium halides are often significantly more soluble in ethereal solvents than in hydrocarbons.

These heteroleptic compounds show a Schlenk‐type equilibrium, interconverting heteroleptic RMgBr into homoleptic MgR2 and MgBr2. Expectedly, this ligand exchange reaction depends on the nature of the solvent (mainly base strength and bulkiness of the Lewis bases). Due to this equilibrium, cooling of the reaction mixture can favor crystallization of the homoleptic compounds as observed for [(thf)2Mg(NPh2)2].

Side reactions slightly reduce the yields which are often nearly quantitative. Wurtz‐type coupling reactions of intermediately formed EtMgBr with EtBr yield magnesium bromide and volatile butane and hence, this side reaction does not produce impurities. Contrary to this side reaction, the metathetical formation of R−Et via the reaction of EtBr with already formed RMgBr causes impurities.

Execution of this iGMM in a sealed NMR tube shows the evolution of ethene. The observation of this molecule suggests a β‐hydride elimination from intermediately formed EtMgBr on the surface of the alkaline‐earth metal particles. This proposal has been verified by repetition of the reaction of Mg turnings with EtBr in the absence of any H‐acidic substrate concluding that ethene formation occurs regardless of the presence of additional H‐acidic substrates.

The bromide ion exhibits intermediate basicity and hardness. Therefore, a multifaceted coordination behavior has been observed in the solid state and in solution. Bromide ions can bind terminally as observed for the pyrazolate derivatives and can adopt μ‐ (as for example in cyclopentadienide complexes) or μ3‐bridging positions (as found in heteroleptic imides).

In summary, the iGMM is a powerful straightforward strategy for large‐scale synthesis of many magnesium reagents. Schlenk‐type equilibria may interconnect homoleptic into heteroleptic species and vice versa. The procedure proceeds smoothly within very few hours via the addition of EtBr to a suspension of magnesium and H‐acidic substrate in an ethereal solvent. Preconditions include solubility of H‐acidic substrates and organylmagnesium products RMgBr and MgR2 to safely exclude precipitation onto the Mg particles. This straightforward synthesis of magnesium reagents offers advantages such as low‐priced starting materials and a time‐economic process compared to other procedures.

Experimental Section

General information: All manipulations were carried out under an inert nitrogen atmosphere using standard Schlenk techniques, if not otherwise noted. The solvents were dried over KOH and subsequently distilled over sodium/benzophenone under a nitrogen atmosphere prior to use. All substrates were purchased from Alfa Aesar, abcr, Sigma Aldrich or TCI and used without further purification. 3,6‐Dimethylcarbazole [48] and HN(C6F5)2 [49] were synthesized as described in the literature. The yields given are not optimized. Purity of the compounds was verified by NMR spectroscopy. Deuterated solvents were dried over sodium, distilled, degassed, and stored under nitrogen over sodium. 1H, and 13C{1H} NMR spectra were recorded on Bruker Avance I 250 (BBO) Bruker Avance III 400 (BBO, BBFO probes Avance neo 500 (BBFO Prodigy probe) and Avance III HD 600 (TCI cryoprobe) spectrometers. Chemical shifts are reported in parts per million relatively to SiMe4 as an external standard referenced to the solvents residual proton signal using the xiref AU program for 13C NMR spectra. DOSY NMR spectra were measured using the convection compensated dstebpgp3s standard pulse sequence. Molar masses in solution were calculated using the Stalke‐ECC‐DOSY method (standard: adamantane or Si(SiMe3)4). [50] ASAP‐HSQC‐spectra and ASAP‐HSQC‐DEPT‐spectra were recorded using the published pulse sequences. [51] NOAH experiments were performed using the GENESIS tool [52] based on the published pulse programs. [53]

General procedure of iGMM with amines: Magnesium (10 mmol, 1 equiv.) and amine (10 mmol, 1 equiv.) were suspended in an ethereal solvent (10–20 mL, 0.5–1 M). EtBr (10 mmol, 1 equiv.) was added in 2–5 portions over 30 min at room temperature. The reaction mixture was stirred for one hour at room temperature. The conversion to the amide was determined by titration of a hydrolyzed aliquot with sulphuric acid (0.1 N) against phenolphthalein or by Gilman titration of an aliquot with benzoic acid against 4‐phenyl‐azo‐diphenylamine. Typical yields are in the range of 40 to 95 %.

[(thf)3Mg{N(C6F5)2}(Br)]: Magnesium turnings (70 mg, 2.9 mmol, 1 equiv.) and HN(C6F5)2 (1 g, 2.9 mmol, 1 equiv.) were suspended in THF (3 mL) and EtBr (220 μL, 2.9 mmol, 1 equiv.) was added in one portion. After 30 minutes an excess of EtBr (0.5 equiv.) was added, and the reaction mixture was stirred for 60 min at room temperature. The colorless solution was stored at 4 °C for 24 h, yielding the amide as colorless blocks. The crystals were collected by filtration and dried carefully in vacuo. Yield: 1.4 g, 2.4 mmol, 82 %, 1H NMR (400 MHz, [D8]THF, 297 K)=3.64 (m, 12 H, thf), 1.80 (m, 12H, thf) ppm; 13C NMR (101 MHz, [D8]THF, 297 K)=141.5 (d, J=233.6 Hz), 137.9 (d, J=248.8 Hz), 132.3 (d, J=239.3 Hz), 68.8, 26.7 ppm; 19F NMR (376.5 MHz, [D8]THF, 297 K)=‐159.2 (s, 2F, o), −169.0 (t, J=21.5 Hz, 2F, m), −177.9 (1F, p) ppm, IR (ATR, n [cm−1])=2980 (w), 2892 (w), 1499 (vs), 1469 (s), 1191 (m), 1023 (vs), 1003 (vs), 878 (m).

[(Et2O)6Mg6(N‐p‐Tol)4(Br)4]: p‐Toluidine (3.00 g, 28 mmol, 1 equiv.) and magnesium turnings (1.43 g, 59 mmol, 2.1 equiv.) were suspended in Et2O (30 mL) and EtBr (4.39 mL, 59 mmol, 2.1 equiv.) was added dropwise over 30 min. After addition of one eq. EtBr a colorless precipitate was observed, which redissolved completely after addition of the second eq. of EtBr. The reaction mixture was heated to reflux for two hours, 1,4‐dioxane (2.5 mL, 1 equiv.) was added slowly at room temperature and the precipitate settled overnight at room temperature. The suspension was filtered (G3, diatomaceous earth), washed with Et2O and the volume of the filtrate was reduced to 1/5 under reduced pressure. Toluene (20 mL) was added and the colorless solution was stored at room temperature for 24 h. A few colorless crystals of [(Et2O)MgBr2]2 precipitated. The mother liquor was decanted, all solvents were removed in vacuo and the residue was redissolved in Et2O (20 mL). After storage for 24 h at room temperature the crystalline precipitate was collected and dried carefully under reduced pressure. [(Et2O)6Mg6(N‐p‐Tol)4(Br)4] (3.73 g, 4.18 mmol, 59 %) was isolated as colorless blocks. 1H NMR (400 MHz, [D]8‐Tol, 297 K)=1.00 (t, J=6.9 Hz, 36H, Et2O), 2.31 (s, 12H, p‐Tol), 3.71 (q, J=6.9 Hz, 24H, Et2O), 6.88 (d, J=8.3 Hz, 8H, p‐Tol), 7.25 (d, J=8.3 Hz, 8H, p‐Tol) ppm, 13C NMR (101 MHz, [D]8‐Tol, 297 K)=12.8, 20.4, 64.1, 120.5, 124.2, 128.8, 137.0, 161.2 ppm, 15N NMR (40.6 MHz, [D]8‐Tol, 297 K)=108 ppm, IR (ATR, n [cm−1])=2970 (w), 2921 (w), 2864 (w), 1600 (m), 1507 (s), 1240 (s), 1222 (s), 1039 (m), 890 (m).

[(thf)3Mg(3,6‐Me2Carb)(Br)] (NMR scale): 3,6‐Dimethylcarbazole (30.1 mg, 154 μmol, 1 equiv.) and magnesium (turnings, 7.5 mg, 308 μmol, 2 equiv.) were suspended in [D8]THF (550.0 μL) and EtBr (11.4 μL, 154 μmol, 1 equiv.) was added in one portion. 1H NMR (400 MHz, [D8]THF, 297 K): δ=7.72 (s, 2H, CzH), 7.52 (d, 2H, CzH), 6.98 (d, 2H, CzH), 2.45 (s, 6H, CH3 ), 13C NMR: (100 MHz, [D8]THF, 297 K): δ=148.6 (CzC), 124.9 (CzC), 124.3 (CzC), 122.5 (CzC), 118.9 (CzC), 113.2 (CzC), 20.9 (CH3).

[(Et2O)(Br)Mg‐μ‐(3,5‐Me2pz)2‐Mg(Br)(OEt2)]: 3,5‐Dimethylprazole (1.0 g, 10.4 mmol, 1 equiv.) and magnesium (turnings, 0.25 g, 10.4 mmol, 1 equiv.) were suspended in Et2O (10.5 mL) and EtBr (0.77 mL, 10.4 mmol, 1 equiv.) was added in three portions over 30 min. During the addition of EtBr a colorless amorphous solid began to precipitate. The reaction mixture was stirred overnight at room temperature. The solvent was removed under reduced pressure and the residue was dissolved in hot toluene (10 mL). Storage at −20 °C for 24 h yielded the pyrazolate as large colorless blocks. The precipitate was collected on a G2 frit and dried carefully under reduced pressure. Yield: 4.7 g, 8.4 mmol, 82 %. Analytical data for [(Et2O)(Br)Mg‐μ‐(3,5‐Me2pz)2‐Mg(Br)(OEt2)] (major compound): 1H NMR (400 MHz, C6D6, 297 K): δ=5.79 (s, 1H), 3.27 (q, J=6.7 Hz, Et2O), 2.50 (s, 6H), 1.00 (t, J=6.7 Hz, 13C NMR (101 MHz, C6D6, 297 K): δ =151.7, 105.8, 65.5, 14.7, 13.4; Analytical data for [(Et2O)(Br)Mg‐μ‐(3,5‐Me2pz)2‐μ‐Et2O−Mg(Br)(OEt2)] (minor compound): 1H NMR (400 MHz, C6D6, 297 K): δ=5.68 (s, 1H), 3.27 (q, J=6.7 Hz, Et2O), 2.29 (s, 3H), 2.17 (s, 3H), 1.00 (t, J=6.7 Hz, 13C NMR (101 MHz, C6D6, 297 K): δ =151.1, 105.5, 65.5, 14.7, 12.8.

Crystal structure determinations: The intensity data for the compounds were collected on a Nonius KappaCCD diffractometer using graphite‐monochromated Mo‐Kα radiation. Data were corrected for Lorentz and polarization effects; absorption was taken into account on a semi‐empirical basis using multiple‐scans.[ 54 , 55 , 56 , 57 ] The structures were solved by intrinsic methods (SHELXT) [58] and refined by full‐matrix least squares techniques against Fo 2 SHELXL‐2018). [59] All hydrogen atoms were included at calculated positions with fixed thermal parameters. The crystals of [(thf)2Mg(NPh2)2], [(thf)3Mg2(Pz)2Br2], and [{(Et2O)Mg}6(N‐pTol)43‐Br)4] contained large voids, filled with disordered solvent molecules. The size of the voids was 1389, 580, and 385 Å3/unit cell, respectively. Their contribution to the structure factors was secured by back‐Fourier transformation using the SQUEEZE routine of the program PLATON [60] resulting in 533, 156, and 86 electrons/unit cell, respectively. All non‐hydrogen atoms were refined anisotropically. [58] Crystallographic data as well as structure solution and refinement details are summarized in Table S1. XP [61] was used for structure representations.

Supporting Information

Deposition Number(s) 2169046 for [(thf)2Mg(NPh2)2], 2169047 for [(thf)3Mg{N(C6F5)2}Br], 2169048 for [(thf)3Mg2(Pz)2Br2], 2169049 for [(Et2O)Mg(Pz)Br]2, 2169050 for [{(Et2O)Mg}6(N‐pTol)43‐Br)4], and 2169051 for [(Et2O)Mg(TBDMS2Cp)Br] contain(s) the supplementary crystallographic data for this paper. These data are provided free of charge by the joint Cambridge Crystallographic Data Centre and Fachinformationszentrum Karlsruhe Access Structures service.

Conflict of interest

The authors declare no conflict of interest.

1.

Supporting information

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supporting Information

Acknowledgements

We acknowledge the valuable support of the NMR service platform (www.nmr.uni‐jena.de/) of the Faculty of Chemistry and Earth Sciences of the Friedrich Schiller University Jena, Germany. Parts of the equipment were provided by the German Research Foundation (DFG, INST 275/442‐1 FUGG) which we kindly acknowledge. P. Schüler is very grateful to the German Environment Foundation (Deutsche Bundesstiftung Umwelt, DBU, grant no. 20018/578) for a generous Ph.D. grant. Open Access funding enabled and organized by Projekt DEAL.

S. Sengupta, P. Schüler, H. Görls, P. Liebing, S. Krieck, M. Westerhausen, Chem. Eur. J. 2022, 28, e202201359.

Data Availability Statement

The data that support the findings of this study are available in the supplementary material of this article.

References

  • 1. Westerhausen M., Langer J., Krieck S., Glock C., Rev. Inorg. Chem. 2011, 31, 143–184. [Google Scholar]
  • 2. 
  • 2a. Bickelhaupt F., Pure Appl. Chem. 1986, 58, 537–542; [Google Scholar]
  • 2b. Bickelhaupt F., Angew. Chem. 1987, 99, 1020–1035; [Google Scholar]; Angew. Chem. Int. Ed. Engl. 1987, 26, 990–1005; [Google Scholar]
  • 2c. Bickelhaupt F., Pure Appl. Chem. 1990, 62, 699–706; [Google Scholar]
  • 2d. Bickelhaupt F., J. Organomet. Chem. 1994, 475, 1–14; [Google Scholar]
  • 2e. Seyferth D., Organometallics 2009, 28, 1598–1605; [Google Scholar]
  • 2f. Peltzer R. M., Gauss J., Eisenstein O., Cascella M., J. Am. Chem. Soc. 2020, 142, 2984–2994. [DOI] [PubMed] [Google Scholar]
  • 3. 
  • 3a. Eaton P. E., Lee C. H., Xiong Y., J. Am. Chem. Soc. 1989, 138, 8016–8018; [Google Scholar]
  • 3b. Shilai M., Kondo Y., Sakamoto T., J. Chem. Soc. Perkin Trans. 1 2001, 442–444. [Google Scholar]
  • 4. Lochmann L., Eur. J. Inorg. Chem. 2000, 1115–1126. [Google Scholar]
  • 5. 
  • 5a. Mulvey R. E., Chem. Commun. 2001, 1049–1056 ; [Google Scholar]
  • 5b. Mulvey R. E., Organometallics 2006, 25, 1060–1075; [Google Scholar]
  • 5c. Mulvey R. E., Mongin F., Uchiyama M., Kondo Y., Angew. Chem. 2007, 119, 3876–3899; [DOI] [PubMed] [Google Scholar]; Angew. Chem. Int. Ed. 2007, 46, 3802–3824; [DOI] [PubMed] [Google Scholar]
  • 5d. Mulvey R. E., Acc. Chem. Res. 2009, 42, 743–755; [DOI] [PubMed] [Google Scholar]
  • 5e. Martinez-Martinez A. J., Kennedy A. R., Mulvey R. E., O'Hara C. T., Science 2014, 346, 834–837; [DOI] [PubMed] [Google Scholar]
  • 5f. Martinez-Martinez A. J., Armstrong D. R., Conway B., Fleming B. J., Klett J., Kennedy A. R., Mulvey R. E., Robertson S. D., O'Hara C. T., Chem. Sci. 2014, 5, 771–781; [Google Scholar]
  • 5g. Robertson S. D., Uzelac M., Mulvey R. E., Chem. Rev. 2019, 119, 8332–8405. [DOI] [PubMed] [Google Scholar]
  • 6. Caubière P., Chem. Rev. 1993, 93, 2317–2334. [Google Scholar]
  • 7. 
  • 7a. Blasberg F., Bolte M., Wagner M., Lerner H.-W., Organometallics 2012, 31, 1001–1005; [Google Scholar]
  • 7b. Klatt T., Markiewicz J. T., Sämann C., Knochel P., J. Org. Chem. 2014, 79, 4253–4269; [DOI] [PubMed] [Google Scholar]
  • 7c. Bao R. L.-Y., Zhao R., Shi L., Chem. Commun. 2015, 51, 6884–6900; [DOI] [PubMed] [Google Scholar]
  • 7d. Ziegler D. S., Wei B., Knochel P., Chem. Eur. J. 2019, 25, 2695–2703. [DOI] [PubMed] [Google Scholar]
  • 8. 
  • 8a. Haag B., Mosrin M., Ila H., Malakhov V., Knochel P., Angew. Chem. 2011, 123, 9968–9999; [DOI] [PubMed] [Google Scholar]; Angew. Chem. Int. Ed. 2011, 50, 9794–9824; [DOI] [PubMed] [Google Scholar]
  • 8b. Benischke A. D., Ellwart M., Becker M. R., Knochel P., Synthesis 2016, 48, 1101–1107; [Google Scholar]
  • 8c. Martinez-Martinez A. J., O'Hara C. T., Adv. Organomet. Chem. 2016, 65, 1–46; [Google Scholar]
  • 8d. Kremsmair A., Harenberg J. H., Schwärzer K., Hess A., Knochel P., Chem. Sci. 2021, 12, 6011–6019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. 
  • 9a. Westerhausen M., Gärtner M., Fischer R., Langer J., Yu L., Reiher M., Chem. Eur. J. 2007, 13, 6292–6306; [DOI] [PubMed] [Google Scholar]
  • 9b. Westerhausen M., Gärtner M., Fischer R., Langer J., Angew. Chem. 2007, 119, 1994–2001; [DOI] [PubMed] [Google Scholar]; Angew. Chem. Int. Ed. 2007, 46, 1950–1956; [Google Scholar]
  • 9c. Westerhausen M., Langer J., Krieck S., Fischer R., Görls H., Köhler M., Top. Organomet. Chem. 2013, 45, 29–72; [Google Scholar]
  • 9d. Westerhausen M., Koch A., Görls H., Krieck S., Chem. Eur. J. 2017, 23, 1456–1483. [DOI] [PubMed] [Google Scholar]
  • 10. 
  • 10a. Hauser C. R., Walker H. G., J. Am. Chem. Soc. 1947, 69, 295–297; [Google Scholar]
  • 10b. Frostick F. C., Hauser C. R., J. Am. Chem. Soc. 1949, 71, 1350–1352; [Google Scholar]
  • 10c. Hauser C. R., Hance C. R., J. Am. Chem. Soc. 1951, 73, 5846–5848. [Google Scholar]
  • 11. 
  • 11a. Neufeld R., Stalke D., Chem. Eur. J. 2016, 22, 12624–12628; [DOI] [PubMed] [Google Scholar]
  • 11b. Neufeld R., Teuteberg T. L., Herbst-Irmer R., Mata R. A., Stalke D., J. Am. Chem. Soc. 2016, 138, 4796–4806. [DOI] [PubMed] [Google Scholar]
  • 12. Krieck S., Schüler P., Peschel J. M., Westerhausen M., Synthesis 2019, 51, 1115–1122. [Google Scholar]
  • 13. Dongmo S., Zaubitzer S., Schüler P., Krieck S., Jörissen L., Wohlfahrt-Mehrens M., Westerhausen M., Marinaro M., ChemSusChem 2020, 13, 3530–3538. [DOI] [PubMed] [Google Scholar]
  • 14. Schüler P., Sengupta S., Zaubitzer S., Fiesinger F., Dongmo S., Görls H., Wohlfahrt-Mehrens M., van den Borg M., Gaissmaier D., Krieck S., Marinaro M., Jacob T., Westerhausen M., Eur. J. Inorg. Chem. 2022, e202200149. [Google Scholar]
  • 15. Garcia-Álvarez P., Graham D. V., Hevia E., Kennedy A. R., Klett J., Mulvey R. E., O'Hara C. T., Weatherstone S., Angew. Chem. 2008, 120, 8199–8201; [DOI] [PubMed] [Google Scholar]; Angew. Chem. Int. Ed. 2008, 47, 8079–8081. [DOI] [PubMed] [Google Scholar]
  • 16. Yang K.-C., Chang C.-C., Huang J.-Y., Lin C.-C., Lee G.-H., Wang Y., Chiang M. Y., J. Organomet. Chem. 2002, 648, 176–187. [Google Scholar]
  • 17. Cole M. L., Junk P. C., Z. Anorg. Allg. Chem. 2015, 641, 2624–2629. [Google Scholar]
  • 18. 
  • 18a. Edelmann F. T., Adv. Organomet. Chem. 2008, 57, 183–352; [Google Scholar]
  • 18b. Jones C., Coord. Chem. Rev. 2010, 254, 1273–1289; [Google Scholar]
  • 18c. Stasch A., Jones C., Dalton Trans. 2011, 40, 5659–5672; [DOI] [PubMed] [Google Scholar]
  • 18d. Chlupatý T., Růžička A., Coord. Chem. Rev. 2016, 314, 103–113. [Google Scholar]
  • 19. Andews P. C., Bryn M., Jones C., Junk P. C., Kloth M., Inorg. Chim. Acta 2006, 359, 355–363. [Google Scholar]
  • 20. 
  • 20a. Langer J., Krieck S., Fischer R., Görls H., Walther D., Westerhausen M., Organometallics 2009, 28, 5814–5820; [Google Scholar]
  • 20b. Fischer R., Görls H., Meisinger P. R., Suxdorf R., Westerhausen M., Chem. Eur. J. 2019, 25, 12830–12841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Hascall T., Olmstead M. M., Power P. P., Angew. Chem. 1994, 106, 1056–1057; [Google Scholar]; Angew. Chem. Int. Ed. Engl. 1994, 33, 1000–1001. [Google Scholar]
  • 22. 
  • 22a. Jutzi P., Adv. Organomet. Chem. 1986, 26, 217–295; [Google Scholar]
  • 22b. Jutzi P., J. Organomet. Chem. 1990, 400, 1–17; [Google Scholar]
  • 22c. Hanusa T. P., Chem. Rev. 1993, 93, 1023–1036; [Google Scholar]
  • 22d. Burkey D. J., Hanusa T. P., Comments Inorg. Chem. 1995, 17, 41–77; [Google Scholar]
  • 22e. Bridgeman A. J., J. Chem. Soc. Dalton Trans. 1997, 2887–2893 ; [Google Scholar]
  • 22f. Jutzi P., Burford N. in Metallocenes: Synthesis, Reactivity, Applications, Vol. 1 (Eds.: Togni A., Halterman R. L.), Wiley-VCH, Weinheim, 1998, pp. 3–54; [Google Scholar]
  • 22g. Long: N. J. Metallocenes: An Introduction to Sandwich Complexes, Blackwell Science, Oxford, 1998; [Google Scholar]
  • 22h. Jutzi P., Burford N., Chem. Rev. 1999, 99, 969–990; [DOI] [PubMed] [Google Scholar]
  • 22i. Jutzi P., Reumann G., J. Chem. Soc. Dalton Trans. 2000, 2237–2244 ; [Google Scholar]
  • 22j. Hanusa T. P., Organometallics 2002, 21, 2559–2571; [Google Scholar]
  • 22k. Budzelaar P. H. M., Engelberts J. J., van Lenthe J. H., Organometallics 2003, 22, 1562–1576. [Google Scholar]
  • 23. Westerhausen M., Makropoulos N., Wieneke B., Karaghiosoff K., Nöth H., Schwenk-Kircher H., Knizek J., Seifert T., Eur. J. Inorg. Chem. 1998, 965–971. [Google Scholar]
  • 24. Morley C. P., Jutzi P., Krüger C., Wallis J. M., Organometallics 1987, 6, 1084–1090. [Google Scholar]
  • 25. Huber M., Schnöckel H., Inorg. Chim. Acta 2008, 361, 457–461. [Google Scholar]
  • 26.T. Duan, H. Schnöckel, private CSD communication REVNOW, 2005.
  • 27.T. Duan, H. Schnöckel, private CSD communication REVNIQ, 2005.
  • 28. Dohmeier C., Loos D., Robl C., Schnöckel H., Fenske D., J. Organomet. Chem. 1993, 448, 5–8. [Google Scholar]
  • 29. Schüler P., Görls H., Krieck S., Westerhausen M., Chem. Eur. J. 2021, 27, 15508–15515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. 
  • 30a. Harder S., Chem. Commun. 2012, 48, 11165–11177; [DOI] [PubMed] [Google Scholar]
  • 30b. Roy M. M. D., Omana A. A., Wilson A. S. S., Hill M. S., Aldrige S., Rivard E., Chem. Rev. 2021, 121, 20, 12784–12965. See also: C. Bakewell, Dalton Trans. 2020, 49, 11354–11360. [DOI] [PubMed] [Google Scholar]
  • 31. 
  • 31a. Walborsky H. M., Acc. Chem. Res. 1990, 23, 286–293; [Google Scholar]
  • 31b. Garst J. F., Acc. Chem. Res. 1991, 24, 95–97; [Google Scholar]
  • 31c. Hamdouchi C., Topolski M., Goedken V., Walborsky H. M., J. Org. Chem. 1993, 58, 3148–3155; [Google Scholar]
  • 31d. Garst J. F., Soriaga M. P., Coord. Chem. Rev. 2004, 248, 623–652. [Google Scholar]
  • 32. Gärtner M., Fischer R., Langer J., Görls H., Walther D., Westerhausen M., Inorg. Chem. 2007, 46, 5118–5124. [DOI] [PubMed] [Google Scholar]
  • 33. Xia A., Heeg M. J., Winter C. H., Organometallics 2002, 21, 4718–4725. [Google Scholar]
  • 34. Fischer C. A., Rösch A., Elsen H., Ballmann G., Wiesinger M., Langer J., Färber C., Harder S., Dalton Trans. 2019, 48, 6757–6766. [DOI] [PubMed] [Google Scholar]
  • 35. Snyder C. J., Heeg M. J., Winter C. H., Inorg. Chem. 2011, 50, 9210–9212. [DOI] [PubMed] [Google Scholar]
  • 36. Pfeiffer D., Heeg M. J., Winter C. H., Angew. Chem. 1998, 110, 2674–2676; [DOI] [PubMed] [Google Scholar]; Angew. Chem. Int. Ed. 1998, 37, 2517–2519. [DOI] [PubMed] [Google Scholar]
  • 37. Mösch-Zanetti N. C., Ferbinteanu M., Magull J., Eur. J. Inorg. Chem. 2002, 950–956. [Google Scholar]
  • 38. Kloubert T., Müller C., Krieck S., Schotthauer T., Görls H., Westerhausen M., Eur. J. Inorg. Chem. 2012, 5991–6001. [Google Scholar]
  • 39. Hascall T., Ruhlandt-Senge K., Power P. P., Angew. Chem. 1994, 106, 350–351; [Google Scholar]; Angew. Chem. Int. Ed. Engl. 1994, 33, 356–357. [Google Scholar]
  • 40. Grigsby W. J., Hascall T., Ellison J. J., Olmstead M. M., Power P. P., Inorg. Chem. 1996, 35, 3254–3261. [DOI] [PubMed] [Google Scholar]
  • 41. Wolf B. M., Anwander R., Chem. Eur. J. 2019, 25, 8190–8202. [DOI] [PubMed] [Google Scholar]
  • 42. de Bruin-Dickason C. N., Deacon G. B., Jones C., Junk P. C., Wiecko M., Eur. J. Inorg. Chem. 2019, 1030–1038. [Google Scholar]
  • 43. 
  • 43a. Tan D., Garcia F., Chem. Soc. Rev. 2019, 48, 2274–2292; [DOI] [PubMed] [Google Scholar]
  • 43b. Jedrzkiewicz D., Langer J., Harder S., Z. Anorg. Allg. Chem. 2022, e202200138. [Google Scholar]
  • 44. Boyde N. C., Rightmire N. R., Hanusa T. P., Brennessel W. W., Inorganics 2017, 5, 36. [Google Scholar]
  • 45. Koby R. F., Doerr A. M., Rightmire N. R., Schley N. D., Long B. K., Hanusa T. P., Angew. Chem. 2020, 132, 9629–9635; [DOI] [PubMed] [Google Scholar]; Angew. Chem. Int. Ed. 2020, 59, 9542–9548. [DOI] [PubMed] [Google Scholar]
  • 46. Berton M., Sheehan K., Adamo A., McQuade D. T., Beilstein J. Org. Chem. 2020, 16, 1343–1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Matsubara H., Niwa Y., Matake R., Synlett 2015, 26, 1276–1280. [Google Scholar]
  • 48. Dalvi B. A., Lokhande P. D., Tetrahedron Lett. 2018, 59, 2145–2149. [Google Scholar]
  • 49. Koppang R., Acta Chem. Scand. 1971, 25, 3067–3071. [Google Scholar]
  • 50. Neufeld R., Stalke D., Chem. Sci. 2015, 6, 3354–3364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. 
  • 51a. Schulze-Sünnighausen D., Becker J., Luy B., J. Am. Chem. Soc. 2014, 136, 1242–1245; [DOI] [PubMed] [Google Scholar]
  • 51b. Schulze-Sünnighausen D., Becker J., Koos M. R. M., Luy B., J. Magn. Reson. 2017, 281, 151–161. [DOI] [PubMed] [Google Scholar]
  • 52. Yong J. R. J., Kupče Ē., Claridge T. D. W., Anal. Chem. 2022, 94, 2271–2278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. 
  • 53a. Kupče Ē., Claridge T. D. W., Angew. Chem. 2017, 129, 11941–11945; [Google Scholar]; Angew. Chem. Int. Ed. 2017, 56, 11779–11783; [DOI] [PubMed] [Google Scholar]
  • 53b. Yong J. R. J., Hansen A. L., Kupče Ē., Claridge T. D. W., J. Magn. Reson. 2021, 329, 107027. [DOI] [PubMed] [Google Scholar]
  • 54.R. Hooft: COLLECT, Data Collection Software; Nonius B. V., Netherlands, 1998.
  • 55. Otwinowski Z., Minor W., in Methods in Enzymology (Eds. Carter C. W., Sweet R. M.), vol. 276 , part A, Academic Press, San Diego, USA, 1997, pp. 307–326. [DOI] [PubMed] [Google Scholar]
  • 56. 
  • 56a.SADABS 2.10, Bruker-AXS Inc., 2002, Madison, WI, USA;
  • 56b.SADABS 2016/2: Krause L., Herbst-Irmer R., Sheldrick G. M., Stalke D., J. Appl. Crystallogr. 2015, 48, 3–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Bruker (2020) APEX3 Bruker AXS LLC, Madison, WI, USA.
  • 58. Sheldrick G. M., Acta Crystallogr. Sect. A 2015, 71, 3–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Sheldrick G. M., Acta Crystallogr. Sect. C 2015, 71, 3–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Spek A. L., Acta Crystallogr. Sect. C 2015, 71, 9–18. [DOI] [PubMed] [Google Scholar]
  • 61.XP, Siemens Analytical X-ray Instruments Inc., Karlsruhe, Germany, 1990; Madison, WI, USA, 1994.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supporting Information

Data Availability Statement

The data that support the findings of this study are available in the supplementary material of this article.


Articles from Chemistry (Weinheim an Der Bergstrasse, Germany) are provided here courtesy of Wiley

RESOURCES